In March 2020, telemedicine became essential not only in the U.S. but to the entire world, as we faced the uncertainty of a global coronavirus pandemic. Almost overnight, technology became paramount in healthcare and telehealth and telemedicine programs became top level advertising. While we’ve been relatively fortunate with this transition, believe it or not, there are villages across this planet that have experienced decades of limited-to-no access to simple medical equipment, qualified healthcare professionals or sanitary treatment facilities.
In Africa, this is a major problem.
According to the World Health Organization, there’s currently one doctor for every 20,000 patients in Tanzania. In Sierra Leone, there are a total of 3 physicians per every 100,000. And according to GlobalVoices.org, “ At the peak of COVID-19 in 2020, the Central African Republic, a country of about 5 million people, had just 3 ventilators.”
That’s where Xcelerate, Inc. is stepping up to the charge.
Socially Responsible, XCRT ‘Xcelerates’ The Growth And Impact by Delivering Of World-Class Healthcare Solutions.
Xcelerate Inc (OTCMKTS: XCRT) takes the power of medtech to a whole new level, reimagining the full potential of existing non-medical technologies by bridging the divide between quality healthcare and accessibility.
This early-stage startup uses artificial intelligence (AI), augmented reality (AR), the Internet of Things (IoT) and wearable technologies to assist patients who often live in remote villages or in areas where healthcare is simply out of reach. The company provides both patients and their doctors with a means of overcoming obstacles related to travel and distance and provides them with the simple tools and solutions necessary to conduct medical diagnostics testing – no matter the distance.
In January 2022, the company announced that it would acquire a 51% majority control of AfiyaSasa Africa, LLC (ASA) and that it was committed to launching a series of programs that would change the way small villages would access healthcare altogether.
For some, a regular check-up is often out of the question. But thanks to recent advancements in technology, Xcelerate is able to fill this void from a medical standpoint, helping patients overcome major hurdles preventing patients from maintaining their basic healthcare needs.
Xcelerate has assembled an internationally renowned team of clinicians, thought leaders, Nobel Prize Winners, Ivy League Graduates, engineers, and business professionals, who have made it their mission to identify and acquire cutting-edge technologies that would improve the world of healthcare outside of the traditional clinical setting.
The company’s CEO, Mr. Michael O’Shea, is himself a forensic accountant with over 35 years of expertise in international investigations, corporate due diligence, and crisis management as well as functioning as a court-appointed receiver of distressed businesses including medical practices.
AdviNOW Is Proof That Unrealized Applications In Non-Medical Society Could Revolutionize The Way We Practice Medicine.
Built on the same infrastructure that powers autonomous driving, Xcelerate’s AdviNOW virtual telehealth portal allows patients to connect with the outside medical community via compatible mobile devices. Many of these villages desperately lack the critical infrastructure they need to carry out quality medical care and treatment. There are very few, if any, medical professionals available, and it’s rather difficult to otherwise get to one.
The system is equipped with facial recognition and access to sensitive patient data stored onto a cloud server. Only returning patients can access this data via their cell phones, and only licensed physicians and medical personnel can conduct initial check-in and triage to determine the most appropriate medical course of action.
Physicians will interview their patients through individual, face-to-face telehealth visits.
Measurements are taken through connected medical devices and may include everything from a stethoscope to a thermometer to a pulse oximeter. Basic triage and vital records are also recorded in this manner. Family health histories and mental illness may also be noted. Medications can be prescribed. Diagnoses will be considered.
The systems are further set up to work and facilitate use in conjunction with robotic surgery, as well as the case for augmented and virtual reality systems for use in medical procedures.
Tanzania To Be The First Country To Receive Technologies In Humanitarian Efforts
On March 14, 2022, Seeking Alpha broke down Xcelerate’s plans to launch a pilot program in Tanzania later this quarter.
Under the namesake of its now wholly-owned subsidiary, The AfiyaSasa Tanzania Project will be launched at 4 different hospitals across the country – each with its own range of services and telehealth capabilities, including:
- Kilimanjaro Christian Medical Centre (KCMC)
- NSK Hospitals
- Arusha Lutheran Medical Center (ALMC)
- Haydon Lutheran Hospital
A possible program at a fifth hospital, Jakaya Kikwete Cardiac Institute, is in the works, as it has expressed a sincere interest in joining the pilot program.
The initial reach of the program would represent a total catchment area of approximately 20 million potential patients – a significant number, considering Tanzania has close to 60.8 million residents, and many of whom are in desperate need of some sort of medical attention.
Once the pilot program has been established, tested, and widely accepted by both patients and physicians, the company will continue rolling out similar projects at hospitals and outreach clinics throughout Tanzania and other parts of Africa.
Xcelerate foresees the success of its fully-operational beta sites by the end of Q3 2022, and that revenue will begin before the end of 2022.
Globally, Equity Funding For Digital Health Hit All-Time High Of $26.5 Billion In 2020
Given the recent demand for telemedicine and how it has impacted the entire industry, it’s essential to know and understand that the bulk of Xcelerate’s business actually comes from its acquisition and licensing of patented intellectual properties.
The company’s team of engineers, physicians and thought-leaders come together as a united front to identify, acquire, and develop existing non-medical technologies for use in a controlled, clinical-care setting. This often includes improvements to already popular technologies – or the modification of said technologies for use in the medical field.
By securing patents for existing, non-medical devices and their unrealized application in the medical realm could bode well on account of advanced engineering and medicine.
Reintroducing cutting-edge products as purposeful medical technologies could open new doors to future breakthroughs in the medical industry. Likewise, it could provide doctors with an alternative of retrofitting surgical equipment for use and implementation, should the situation call for one.
Xcelerate considers itself a clinical / medtech incubator, acquiring innovative startups and nurturing their ideas through ongoing research and development. And while the company is interested in taking these ideas to market.
While the company services several different verticals and has created multiple revenue streams, its primary source of revenue is generated through licensing fees.
Reliance on standard, ground-up research and development is also reduced – and also eliminated – through this approach.
Xcelerate’s first acquisition was a patent license for material initially developed for use in the heat wicking of gun barrels. Since then, this concept has evolved into a series of patents that apply this same material to high heat-generating surgical instruments.
After obtaining exclusive rights to this advanced metal alloy technology, a layer of coating was implemented in the final development of a high-precision surgical drill. By reducing the friction and buildup of heat in the equipment itself, the company created a design for a breakthrough product with an improved tolerance to vibration and a low propensity towards overheating.
The Future Appears Bright For MedTech’s Rising Star
Xcelerate operates with next to zero overhead expenses and currently holds no debt for which it is to be held accountable. Within the next few months, it plans to uplist from the OTC Pink Markets to the OTCQB, with its eyes set on the Nasdaq in the near future.
The company has submitted its annual audited financial reporting to the U.S. Securities and Exchange Commission (SEC) for years 2019 and 2020 – and now, 2021. It has since received S.E.C. confirmation for a Regulation-A Tier-2 offering, with a timely goal to raise enough capital to rapidly expand upon these projects.